IL18 and inflammatory bowel disease: Thus, our MR analyses support a role of IL18 in IBD susceptibility, with each genetically predicted standard deviation increase in IL18 conferring a 22% increase in odds of IBD (OR = 1.22, 95% CI = 1.11–1.34, p-value = 5.9 × 10−5).